- Differences in High Dose Antipsychotic Prescriptions in Patients with Schizophrenia in Asian Countries/Areas: Findings from the REAP-AP Study
-
Park YC, Yang SY, Chong MY, Kanba S, Sartorius , Shinfuku N, Tan CH, Park SC
- KMID: 2425513
- Psychiatry Investig.
- 2018 Oct;15(10):1007-1008.
- doi: 10.30773/pi.2018.09.06
The REAP-AP study recruited 3,746 patients with schizophrenia, in March and April 2016, from 71 centers in 15 Asian countries/territories namely Bangladesh, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Call for a Rational Polypharmacy Policy: International Insights From Psychiatrists
-
Nakagami Y, Hayakawa K, Horinouchi T, Pereira-Sanchez V, Tan MP, Park SC, Park YC, Moon SW, Choi TY, Avasthi A, Grover S, Kallivayalil RA, Rai Y, Shalbafan M, Chongsuksiri P, Udomratn P, Kathriarachchi ST, Xiang YT, Sim K, Javed A, Chong MY, Tan CH, Lin SK, Inada T, Murai T, Kanba S, Sartorius N, Shinfuku N, Kato TA
- KMID: 2522486
- Psychiatry Investig.
- 2021 Nov;18(11):1058-1067.
- doi: 10.30773/pi.2021.0169
Objective Recently, rational polypharmacy approaches have been proposed, regardless of the lower risk and cost of monotherapy. Considering monotherapy as first-line treatment and polypharmacy as rational treatment, a balanced attitude... -
- CITED
-
- Close
- SHARE
-
- Close
